These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


207 related items for PubMed ID: 18604600

  • 1. Dopamine D4 receptor involvement in the discriminative stimulus effects in rats of LSD, but not the phenethylamine hallucinogen DOI.
    Marona-Lewicka D, Chemel BR, Nichols DE.
    Psychopharmacology (Berl); 2009 Apr; 203(2):265-77. PubMed ID: 18604600
    [Abstract] [Full Text] [Related]

  • 2. Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis.
    Marona-Lewicka D, Thisted RA, Nichols DE.
    Psychopharmacology (Berl); 2005 Jul; 180(3):427-35. PubMed ID: 15723230
    [Abstract] [Full Text] [Related]

  • 3. WAY 100635 produces discriminative stimulus effects in rats mediated by dopamine D(4) receptor activation.
    Marona-Lewicka D, Nichols DE.
    Behav Pharmacol; 2009 Feb; 20(1):114-8. PubMed ID: 19179855
    [Abstract] [Full Text] [Related]

  • 4. LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex.
    Marek GJ, Aghajanian GK.
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1373-82. PubMed ID: 8819525
    [Abstract] [Full Text] [Related]

  • 5. Serotonergic and dopaminergic distinctions in the behavioral pharmacology of (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD).
    Schindler EA, Dave KD, Smolock EM, Aloyo VJ, Harvey JA.
    Pharmacol Biochem Behav; 2012 Mar; 101(1):69-76. PubMed ID: 22197710
    [Abstract] [Full Text] [Related]

  • 6. Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6J mice.
    Benneyworth MA, Smith RL, Barrett RJ, Sanders-Bush E.
    Psychopharmacology (Berl); 2005 Jun; 179(4):854-62. PubMed ID: 15645221
    [Abstract] [Full Text] [Related]

  • 7. The 5-HT1A receptor and the stimulus effects of LSD in the rat.
    Reissig CJ, Eckler JR, Rabin RA, Winter JC.
    Psychopharmacology (Berl); 2005 Oct; 182(2):197-204. PubMed ID: 16025319
    [Abstract] [Full Text] [Related]

  • 8. Potential serotonin 5-HT(1A) and dopamine D(4) receptor modulation of the discriminative stimulus effects of amphetamine in rats.
    Marona-Lewicka D, Nichols DE.
    Behav Pharmacol; 2011 Sep; 22(5-6):508-15. PubMed ID: 21814134
    [Abstract] [Full Text] [Related]

  • 9. LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT(2A) receptor.
    Halberstadt AL, Geyer MA.
    Psychopharmacology (Berl); 2010 Feb; 208(2):179-89. PubMed ID: 19937319
    [Abstract] [Full Text] [Related]

  • 10. The acute effects of monoamine reuptake inhibitors on the stimulus effects of hallucinogens.
    Winter JC, Helsley S, Fiorella D, Rabin RA.
    Pharmacol Biochem Behav; 1999 Jul; 63(3):507-13. PubMed ID: 10418794
    [Abstract] [Full Text] [Related]

  • 11. Phospholipase C mediates (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-, but not lysergic acid diethylamide (LSD)-elicited head bobs in rabbit medial prefrontal cortex.
    Schindler EA, Harvey JA, Aloyo VJ.
    Brain Res; 2013 Jan 23; 1491():98-108. PubMed ID: 23123701
    [Abstract] [Full Text] [Related]

  • 12. Further evidence that the delayed temporal dopaminergic effects of LSD are mediated by a mechanism different than the first temporal phase of action.
    Marona-Lewicka D, Nichols DE.
    Pharmacol Biochem Behav; 2007 Oct 23; 87(4):453-61. PubMed ID: 17618679
    [Abstract] [Full Text] [Related]

  • 13. Discriminative stimulus properties of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane [(+/-)DOI] in C57BL/6J mice.
    Smith RL, Barrett RJ, Sanders-Bush E.
    Psychopharmacology (Berl); 2003 Feb 23; 166(1):61-8. PubMed ID: 12474110
    [Abstract] [Full Text] [Related]

  • 14. Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex.
    Gresch PJ, Smith RL, Barrett RJ, Sanders-Bush E.
    Neuropsychopharmacology; 2005 Sep 23; 30(9):1693-702. PubMed ID: 15756304
    [Abstract] [Full Text] [Related]

  • 15. Hallucinogenic 5-HT2AR agonists LSD and DOI enhance dopamine D2R protomer recognition and signaling of D2-5-HT2A heteroreceptor complexes.
    Borroto-Escuela DO, Romero-Fernandez W, Narvaez M, Oflijan J, Agnati LF, Fuxe K.
    Biochem Biophys Res Commun; 2014 Jan 03; 443(1):278-84. PubMed ID: 24309097
    [Abstract] [Full Text] [Related]

  • 16. Serotonergic/glutamatergic interactions: the effects of mGlu2/3 receptor ligands in rats trained with LSD and PCP as discriminative stimuli.
    Winter JC, Eckler JR, Rabin RA.
    Psychopharmacology (Berl); 2004 Mar 03; 172(2):233-40. PubMed ID: 14598016
    [Abstract] [Full Text] [Related]

  • 17. Involvement of 5-HT2C receptors in mediating the discriminative stimulus properties of m-chlorophenylpiperazine (mCPP).
    Callahan PM, Cunningham KA.
    Eur J Pharmacol; 1994 May 12; 257(1-2):27-38. PubMed ID: 8082704
    [Abstract] [Full Text] [Related]

  • 18. Serotonin type 5A receptor antagonists inhibit D-lysergic acid diethylamide discriminatory cue in rats.
    Popik P, Krawczyk M, Kuziak A, Bugno R, Hogendorf A, Staroń J, Nikiforuk A.
    J Psychopharmacol; 2019 Nov 12; 33(11):1447-1455. PubMed ID: 31452444
    [Abstract] [Full Text] [Related]

  • 19. 5-HT2A/2C receptor agonists potentiate the discriminative cue of (+)-amphetamine in the rat.
    Marona-Lewicka D, Nichols DE.
    Neuropharmacology; 1997 Oct 12; 36(10):1471-5. PubMed ID: 9423936
    [Abstract] [Full Text] [Related]

  • 20. The hallucinogen d-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT1A, D2 and TAAR1 receptors.
    De Gregorio D, Posa L, Ochoa-Sanchez R, McLaughlin R, Maione S, Comai S, Gobbi G.
    Pharmacol Res; 2016 Nov 12; 113(Pt A):81-91. PubMed ID: 27544651
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.